Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2

The current SARS-CoV-2 pandemic forms a major global health burden. Although protective vaccines are available, concerns remain as new virus variants continue to appear. CRISPR-based gene-editing approaches offer an attractive therapeutic strategy as the CRISPR-RNA (crRNA) can be adjusted rapidly to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussein, Mouraya, Andrade dos Ramos, Zaria, Vink, Monique A., Kroon, Pascal, Yu, Zhenghao, Enjuanes, Luis, Zuñiga, Sonia, Berkhout, Ben, Herrera-Carrillo, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051389/
https://www.ncbi.nlm.nih.gov/pubmed/36992394
http://dx.doi.org/10.3390/v15030686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051389/
https://www.ncbi.nlm.nih.gov/pubmed/36992394
http://dx.doi.org/10.3390/v15030686

Ejemplares similares